Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,069 | 71,517 | 96,551 | 88,505 | 15,662 |
| Depreciation Amortization | 19,638 | 68,917 | 51,698 | 34,454 | 17,234 |
| Income taxes - deferred | -6,038 | -78,042 | -63,026 | -62,649 | 0 |
| Accounts receivable | -5,006 | -22,524 | -65,679 | -6,778 | -9,836 |
| Accounts payable and accrued liabilities | -350 | -5,827 | -2,286 | -2,472 | -1,350 |
| Other Working Capital | -33,052 | 13,486 | -39,854 | -25,410 | -20,131 |
| Other Operating Activity | 12,562 | 56,030 | 89,955 | 24,455 | 18,991 |
| Operating Cash Flow | $-25,315 | $103,557 | $67,359 | $50,105 | $20,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -108 | -1,944 | -1,429 | -1,153 | -428 |
| Net Acquisitions | -572,069 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-572,177 | $-1,944 | $-1,429 | $-1,153 | $-428 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 517,682 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -50,000 | -37,500 | -25,000 | -12,500 |
| Common Stock Issued | 3,464 | 12,707 | 10,368 | 8,632 | 4,540 |
| Common Stock Repurchased | N/A | -47,861 | -15,524 | N/A | N/A |
| Other Financing Activity | -3,382 | -4,149 | -4,149 | -3,929 | -3,508 |
| Financing Cash Flow | $517,764 | $-89,303 | $-46,805 | $-20,297 | $-11,468 |
| Beginning Cash Position | 188,973 | 176,663 | 176,663 | 176,663 | 176,663 |
| End Cash Position | 109,245 | 188,973 | 195,788 | 205,318 | 185,337 |
| Net Cash Flow | $-79,728 | $12,310 | $19,125 | $28,655 | $8,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,315 | 103,557 | 67,359 | 50,105 | 20,570 |
| Capital Expenditure | -108 | -1,944 | -1,429 | -1,153 | -428 |
| Free Cash Flow | -25,423 | 101,613 | 65,930 | 48,952 | 20,142 |